Many patients worried about a heart transplant and its success have reportedly found new hope as women in Kentucky, United States recently underwent the world’s first Aeson bioprosthetic total artificial heart implantation. According to a report by The time of science, the 57-year-old man became the first woman and the third person to undergo the implantation on September 14. Previously, two men had undergone the same procedure a few weeks ago.
First successful Aeson bioprosthetic operation
According to EurÃªka alertAccording to the report, the operation was performed at the Jewish Hospital of the University of Louisville Health (UoLH) as part of an early feasibility study (EFS). The study was reportedly sponsored by CARMAT, a French medical device company in partnership with UofL, UofL Health – Jewish Hospital and UofL Health – Trager Transplant Center.
Media sources have reported that the Aeson device implanted in the woman is intended as a bridge to heart transplants. The report of Science time said the device overcomes the limitations of left ventricular assist devices (LVADs) by pumping blood into both chambers of the heart. He further revealed that the device is powered by a portable power supply and is transplanted as a complete replacement of the heart. Interestingly, it contains pressure sensors that estimate blood pressure and automatically adapt cardiac output.
Sequelae of the surgery
The woman, who underwent the operation, suffered from severe biventricular heart failure after eight hours of surgery. However, media sources revealed that she was doing well and recovering well in the hospital’s cardiovascular intensive care unit. According to lead surgeons Mark Slaughter and Siddharth Pahwa, the artificial heart can easily fit into smaller chest cavities, especially in women. Doctors have said that this specialty of the device will increase the success rate and give hope to a large number of patients. They further revealed that the viability and performance of the artificial heart increases due to its variable pumping capacity which helps meet the changing blood flow needs of the human body.
It comes after a 39-year-old patient from Shallotte, North Carolina received the very first CARMAT device in North America. His heart was reportedly replaced by the device after suffering sudden heart failure and when all conventional transplants came out of the options.